Amoxicillin capsules are a distinct oral prescription dosage form available in U.S. product labeling at 250 mg and 500 mg per capsule. A pharmacy listing for “amoxicillin 500 mg” is incomplete until it identifies the dosage form: tablets, capsules and liquid products may share an ingredient name without being the same dispensed item. This guide concentrates on capsule appearance, package identifiers and the information a pharmacy needs to match an existing prescription, not on selecting a dose or an antibiotic.
Capsules also differ across labelers. One documented product uses blue-and-pink shells with A44 or A45 imprints; another uses ivory or caramel-and-ivory shells with West-ward markings. Those examples are useful for recognizing why a legitimate generic can look different from an earlier fill, but appearance alone cannot confirm identity or FDA approval. The pharmacy’s product record, current package information and pharmacist review carry more weight than an online photograph.
Below, the product examples are deliberately dated and qualified. A published DailyMed label is evidence of what that label describes, not proof that the exact package is currently available at a local retailer; some historical NDCs remain mentioned in labeling text even when they are absent from the page’s current NDC summary. The practical goal is to help readers ask precise, capsule-specific questions when checking a licensed pharmacy, while leaving prescription interpretation and substitutions to the prescriber and dispensing pharmacist.
An oral capsule is a finished medicine with a specific formulation, shell, amount of amoxicillin and manufacturer or labeler record. U.S. product labeling describes conventional 250 mg and 500 mg capsules. These are not interchangeable search terms for the tablet product category, and the strength printed on a search result does not, by itself, tell a buyer what physical dosage form is being supplied.
A product listing should identify plain amoxicillin, not amoxicillin/clavulanate. The latter is a separate combination medicine marketed in different product forms and under different labeling, including Augmentin products. Nothing about a familiar amoxicillin strength authorizes replacing one product or dosage form with another without pharmacy and prescriber review.
The entries below are specific label-record examples, not a complete list of U.S. capsule suppliers. They show why the same strength can have different imprints and package configurations. For the A44/A45 family, the DailyMed label was updated March 2, 2024 and its current archive version was published March 5, 2024. For the West-ward/939 family, the other DailyMed label was revised March 2026 and its current archive version was published July 3, 2026. These dates describe labeling versions rather than pharmacy inventory checks.
The NorthStar-labeled 250 mg A44 capsule is blue and pink, with A44 printed in black ink on its pink body. The 500 mg A45 capsule also has a blue-and-pink shell and black lettering on the pink body, but it has a different physical size: the label describes size 1 for A44 and size 0EL for A45, while the structured characteristics list approximately 19 mm and 23 mm respectively. Two capsules can therefore share a color scheme yet differ in both imprint and size.
A separate West-ward/Hikma label describes an ivory 500 mg capsule marked West-ward on the cap and 939 on the body. Its current DailyMed NDC summary includes the 500-count code shown below. Earlier West-ward records also describe a caramel-and-ivory 250 mg capsule marked 938 and smaller bottle presentations, but those historical package NDCs must not be treated as a current retail offer. In particular, the 2026 label text and the current NDC summary do not list the same complete set of legacy packages.
| Label-described product | Imprint and appearance | Example package NDC | Package in label | Label date / scope |
|---|---|---|---|---|
| Amoxicillin capsule 250 mg | A44; blue/pink; 19 mm | 16714-298-01 | 100 capsules per manufacturer bottle | NorthStar label, March 2024 |
| Amoxicillin capsule 500 mg | A45; blue/pink; 23 mm | 16714-299-03 | 100 capsules per manufacturer bottle | NorthStar label, March 2024 |
| Amoxicillin capsule 500 mg | West-ward / 939; ivory | 0143-9939-05 | 500 capsules per manufacturer bottle | Hikma label, revised March 2026 |
A current page may have an older label date because product labeling is revised when needed, not every time a pharmacy orders stock. Conversely, a label section may retain historical product descriptions or packages. For example, the West-ward family has older 250 mg and 500 mg package codes in its descriptive text, while the NDCs displayed in its updated DailyMed summary are restricted to listed 500 mg packages. Treat the description as a documented label example, not evidence that every previously described stock bottle is still marketed.
To make a time-sensitive claim, distinguish three questions: whether FDA has approved the product under the relevant application, whether its NDC appears in a current listing, and whether a specific licensed pharmacy can actually supply it. A record alone cannot answer the last question. Even a currently listed package may be unavailable from a particular pharmacy or wholesaler.
An imprint is most useful when combined with other details, including the capsule’s color, physical shape, printed pharmacy label and the product dispensed on the pharmacy’s record. An A44 capsule is not identified merely by a pink-and-blue shell, because color combinations may be shared across products. Likewise, a West-ward imprint cannot be interpreted from one partial letter or a poor-quality photograph.
When a refill looks different, compare the prescription label to the package received and ask the dispensing pharmacist which labeler or NDC was used. The pharmacist can check the actual inventory record and explain whether the change reflects an approved generic from another source. If a capsule is loose, unidentified, damaged or inconsistent with the label, do not identify it by guesswork or take it before the pharmacy has resolved the discrepancy. For broader reporting and verification concerns, consult the product-authenticity guide.
The National Drug Code (NDC) identifies a listed product and, when the package segment is included, a particular package presentation. The code can help a pharmacy distinguish a 100-count stock bottle from another size for the same capsule product. It is not itself a certificate of approval: FDA explicitly states that an NDC listing can include approved and unapproved products, and the listing data are submitted by labelers.
An ANDA is an application pathway for generic-drug approval. Approval and any therapeutic-equivalence evaluation are checked through FDA approval information such as the Orange Book; capsule appearance and NDC listings serve different identification purposes. The company named as labeler also need not be the physical factory making the capsules, the application holder or the entity that sells a product to a pharmacy.
The example table is intentionally not a company directory. A fuller discussion of corporate roles and individual applications belongs on amoxicillin manufacturers and labelers, while the generic amoxicillin overview covers the medicine’s wider range of approved forms. Here, these identifiers are used only to check whether a capsule order refers to the right product.
A DailyMed package description may identify a manufacturer bottle containing 100 or 500 capsules. Most retail prescriptions involve the pharmacy dispensing the authorized quantity into a patient-labeled container; the original manufacturer bottle may never leave the pharmacy. The number in the manufacturer package record therefore tells you about a distribution presentation, not the number of capsules prescribed to an individual.
The patient label should identify the dispensed medicine, strength, directions, quantity and dispensing pharmacy. If the original stock package is relevant to a specific concern, the pharmacist can trace its NDC and lot records. This is more reliable than comparing the patient vial to a photograph of a bulk container online.
Begin with the written or transmitted prescription. Ask the pharmacist to confirm that it specifies amoxicillin capsules at the stated strength and quantity, rather than a generic catalog entry that happens to contain the words “amoxicillin 500 mg.” If the intended dosage form is unclear, the pharmacy should clarify it with the prescriber as needed.
Next, verify the product that the pharmacy expects to dispense. The capsule must correspond to the authorized prescription; a different labeler or package may be permissible, but that is a professional dispensing determination, not a patient-directed switch. Before pickup or shipment, ask whether the pharmacist has completed verification and whether the item is actually ready. An electronic “received” or “processing” status does not necessarily mean a capsule prescription has been filled.
Capsule shells and excipients can differ between labelers, even when the active ingredient and strength are the same. Inactive-ingredient details should be taken from the exact product’s label rather than a composite list. Tell the pharmacist about relevant ingredient sensitivities, and tell the clinician and pharmacist about any previous serious reaction to penicillin, amoxicillin or related beta-lactam antibiotics before the medicine is dispensed or taken. A serious allergy concern is not solved by choosing a capsule with another color.
Some patients cannot comfortably swallow capsules, but that does not make it appropriate to open, crush or mix the contents without product-specific advice. Ask the pharmacist or prescriber whether the dispensed capsule may be handled differently or whether a new prescription for a different formulation is needed. Liquid and chewable amoxicillin products exist, but they are separate dosage forms with their own labeling and are not automatic replacements.
Published capsule labels generally call for controlled room-temperature storage, but exact handling directions should come from the supplied product and the dispensing pharmacy. The container given to a patient may be a pharmacy vial rather than the original stock bottle. Keep the medicine in its labeled container and protect it according to the instructions provided rather than another labeler’s product photograph.
The expiration or beyond-use date on the dispensed container may reflect the pharmacy’s repackaging and dispensing rules, rather than the date printed on a manufacturer stock bottle. If a label is unreadable, a container arrives damaged, or the quantity cannot be reconciled with the pharmacy record, request a pharmacy review before use.
At a local pharmacy, the immediate question is whether the exact capsule form and strength can be filled after the pharmacist reviews the prescription. A store may have 500 mg amoxicillin tablets but not the prescribed capsules, or it may have a different listed generic capsule from the example the patient remembers. For pickup timing and pharmacist consultation, see local pharmacy fulfillment.
With an online pharmacy, the buyer should identify the licensed dispensing pharmacy behind the website and confirm how it handles product verification, prescription transfer and any shipping limitations. A web catalog photo may not depict the exact generic that is ultimately dispensed. The online pharmacy guide addresses those service questions; this page remains a reference for interpreting capsule-specific product details.
A meaningful price comparison starts with the identical prescribed ingredient, capsule strength and quantity. A tablet listing and a capsule listing with the same milligram number are not automatically equivalent buying options. Likewise, a 100-count manufacturer-bottle NDC should not be assumed to describe the patient’s retail quantity or price.
Request an all-in amount from the dispensing pharmacy that accounts for applicable copays, cash discounts and fees. Actual costs depend on the prescription, plan rules, pharmacy and availability; the capsule record itself establishes no price. Detailed pricing comparisons belong on amoxicillin pricing, not in this product-identification catalog.
Different-looking refill. A person previously received a capsule with a West-ward imprint and now sees A45. Both are documented in capsule labeling, but the relevant question is which product the pharmacy actually dispensed, not whether the two photos look alike. A pharmacist can match the new imprint and supplier information with the prescription and dispensed label.
Incomplete 500 mg online listing. A marketplace displays “amoxicillin 500 mg,” a price and an inventory indicator but does not identify tablets versus capsules. That is insufficient for a capsule-specific order. The dispensing pharmacy should confirm dosage form and fulfillment status before the buyer relies on the offer.
Old package code in a label excerpt. A search result reproduces a West-ward stock-bottle NDC that does not appear in the updated page’s current NDC summary. The historical description may be genuine while the code’s present marketing status is uncertain. The buyer should not infer availability; a pharmacist can check the product being used for the actual fill.
Before using a dispensed amoxicillin capsule, make sure the pharmacy label names plain amoxicillin, gives the prescribed capsule strength and instructions, and shows the intended quantity. If the imprint or shell differs from expectations, or if any allergy or ingredient concern remains unresolved, ask the pharmacist to reconcile the product against its dispensing records before use.
A well-matched capsule order is not a reason to self-select an antibiotic or alter instructions. Antibiotics should be used only when clinically indicated and prescribed. The purpose of a capsule catalog is narrower: to make product identity and dispensing questions precise enough for a pharmacist to answer.
Conventional prescription capsule labels describe 250 mg and 500 mg amoxicillin per capsule. Those amounts identify a product strength, not an amount to take or the total number of capsules supplied. The clinician’s prescription and pharmacy’s verified directions govern use.
Different listed generic products can have different shells, inks, dimensions and imprints. For example, labeling describes a blue-and-pink A45 capsule and an ivory West-ward/939 capsule. Appearance is a clue, not a sufficient identification method, so ask the pharmacist to verify the dispensed product if it changes.
The cited label describes both as blue-and-pink hard gelatin capsules with black printing on the pink body. A44 is the 250 mg product and is listed at approximately 19 mm; A45 is the 500 mg product and is approximately 23 mm. Only a product-specific label and pharmacy record should be used to confirm a dispensed capsule.
No. An NDC identifies a submitted drug listing or package presentation and does not, by itself, demonstrate FDA approval. Nor does a current or historical NDC listing confirm that a particular pharmacy has stock. Approval records, current listings and local availability answer different questions.
Treat it as historical product information rather than proof of a presently marketed package. Some label text retains older packaging descriptions, while the updated NDC summary lists fewer presentations. Ask the pharmacy for the actual product identifier associated with the prescription being filled.
No. The dosage forms have separate product descriptions and may have different inactive ingredients and dispensing records. A prescription written for capsules should not be replaced with tablets solely because the strength number matches. The pharmacist and, where necessary, the prescriber determine lawful and appropriate dispensing.
Not necessarily. The manufacturer package size can describe a stock bottle used by the pharmacy, while the patient receives only the quantity authorized on the prescription. Check the dispensed label and ask the pharmacist if the stock-package code creates confusion.
Do not assume that the contents can be mixed with food or liquid. Ask the pharmacist about administration instructions for the exact product and discuss swallowing concerns with the prescriber. A different dosage form may be available after a professional review, but it is not an automatic substitution.
Disclose any past reaction to amoxicillin, penicillin or related antibiotics, particularly a serious allergic reaction, before the medicine is dispensed or taken. The clinician and pharmacist need the nature of the reaction to assess safety. A different capsule color or manufacturer does not remove an allergy to amoxicillin itself.
Do not guess which medicine was supplied or follow instructions from an online product photo. Keep the dispensed container and contact the pharmacy with the label, imprints, appearance and any NDC available. The pharmacist can check the dispensing record and coordinate with the prescriber if correction is needed before use.